Independent Director · Kymera Therapeutics, Inc. (KYMR)

Chair, Nominating/Governance Committee

Pamela Esposito director compensation at Kymera Therapeutics: $631K

Fiscal year 2025 director compensation for Pamela Esposito at Kymera Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Pamela Esposito’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Pamela Esposito and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Kymera Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Kymera Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$57,583$0$572,996$0$630,579
FY2024$54,375—$302,722—$357,097
FY2023$52,500—$191,464—$243,964

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kymera Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191495, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Kymera Therapeutics, Inc. filed document, accession 0001193125-26-191495. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Get the Kymera Therapeutics Board Governance Report

$630,579 Pamela Esposito, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Kymera Therapeutics pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit · Nominating/Governance (Chair)

The rest of the Kymera Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Bruce BoothIndependent Director$642,996
Elena RidloffIndependent Director$632,996
Felix J. BakerIndependent Director$636,871
Gorjan Hrustanovic Ph.DIndependent Director$617,996
Jeffrey AlbersIndependent Director$637,996
John MaraganoreIndependent Director$620,496
Nello MainolfiDirector—
Victor SandorIndependent Director$612,996

The full Kymera Therapeutics compensation record

free company brief

This page is one director within Kymera Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Kymera Therapeutics proxy · each links to its own free brief

Order KYMR

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report